NCT04913298View on ClinicalTrials.gov

Prospective Study for the Application of Cytosorb® in Critically Ill Patients

NACompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

April 30, 2023

Study Completion Date

December 15, 2023

Conditions
RhabdomyolysisAcute Liver InjuryCytokine Storm
Interventions
DEVICE

Cytosorb therapy

Start of Cytosorb therapy is at the discretion of the attending physician

Trial Locations (1)

81377

LMU munich, Munich

All Listed Sponsors
lead

Ludwig-Maximilians - University of Munich

OTHER

NCT04913298 - Prospective Study for the Application of Cytosorb® in Critically Ill Patients | Biotech Hunter | Biotech Hunter